BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28916732)

  • 1. IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases.
    Hurdayal R; Ndlovu HH; Revaz-Breton M; Parihar SP; Nono JK; Govender M; Brombacher F
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8430-E8439. PubMed ID: 28916732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
    Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
    Front Immunol; 2021; 12():759021. PubMed ID: 35154068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4Ralpha responsiveness of non-CD4 T cells contributes to resistance in schistosoma mansoni infection in pan-T cell-specific IL-4Ralpha-deficient mice.
    Dewals B; Hoving JC; Leeto M; Marillier RG; Govender U; Cutler AJ; Horsnell WG; Brombacher F
    Am J Pathol; 2009 Aug; 175(2):706-16. PubMed ID: 19628763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.
    Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F
    PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis.
    Govender M; Hurdayal R; Martinez-Salazar B; Gqada K; Pillay S; Gcanga L; Passelli K; Nieuwenhuizen NE; Tacchini-Cottier F; Guler R; Brombacher F
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection.
    Mohrs M; Holscher C; Brombacher F
    Infect Immun; 2000 Apr; 68(4):1773-80. PubMed ID: 10722563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.
    Mohrs M; Ledermann B; Köhler G; Dorfmüller A; Gessner A; Brombacher F
    J Immunol; 1999 Jun; 162(12):7302-8. PubMed ID: 10358179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases.
    Palanivel V; Posey C; Horauf AM; Solbach W; Piessens WF; Harn DA
    Exp Parasitol; 1996 Nov; 84(2):168-77. PubMed ID: 8932766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells that produce immunoglobulin E mediate colitis in BALB/c mice.
    Hoving JC; Kirstein F; Nieuwenhuizen NE; Fick LC; Hobeika E; Reth M; Brombacher F
    Gastroenterology; 2012 Jan; 142(1):96-108. PubMed ID: 21983080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4 Receptor Alpha Expressing B Cells Are Essential to Down-Modulate Host Granulomatous Inflammation During Schistosomasis.
    Ndlovu H; Nono JK; Abdel Aziz N; Nieuwenhuizen NE; Brombacher F
    Front Immunol; 2018; 9():2928. PubMed ID: 30619289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
    Noben-Trauth N; Paul WE; Sacks DL
    J Immunol; 1999 May; 162(10):6132-40. PubMed ID: 10229856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of Schistosoma mansoni egg-induced inflammation by IL-4-responsive CD4(+)CD25(-)CD103(+)Foxp3(-) cells is IL-10-dependent.
    Dewals B; Hoving JC; Horsnell WG; Brombacher F
    Eur J Immunol; 2010 Oct; 40(10):2837-47. PubMed ID: 20821727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
    Arendse B; Van Snick J; Brombacher F
    J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of
    Hurdayal R; Nieuwenhuizen NE; Khutlang R; Brombacher F
    Front Cell Infect Microbiol; 2019; 9():479. PubMed ID: 32039054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarized helper-T-cell responses against Leishmania major in the absence of B cells.
    Brown DR; Reiner SL
    Infect Immun; 1999 Jan; 67(1):266-70. PubMed ID: 9864225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice.
    Hölscher C; Arendse B; Schwegmann A; Myburgh E; Brombacher F
    J Immunol; 2006 Jan; 176(2):1115-21. PubMed ID: 16394000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype.
    Bryson KJ; Millington OR; Mokgethi T; McGachy HA; Brombacher F; Alexander J
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e930. PubMed ID: 21245915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4-Responsive B Cells Are Detrimental During Chronic Tuberculosis Infection in Mice.
    Parihar SP; Ozturk M; Höft MA; Chia JE; Guler R; Keeton R; van Rensburg IC; Loxton AG; Brombacher F
    Front Immunol; 2021; 12():611673. PubMed ID: 34220793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.